Characteristics | Young patient group | Senior patient group | P-value |
---|---|---|---|
Total eyes (patients) | 58 (44) | 58 (48) | 0.359 |
Age at operation (years) | 37.52 ± 5.80 | 57.60 ± 9.06 | < 0.001 |
Gender (n, %) | |||
Male | 28 (48.3%) | 29 (50.0%) | 0.853 |
Female | 30 (51.7%) | 29 (50.0%) | 0.853 |
Diabetes mellitus | |||
History (years) | 9.17 ± 6.49 | 13.98 ± 6.89 | < 0.001 |
Therapy (n, %) | |||
Drugs only | 10 (17.2%) | 11 (19.0%) | 0.809 |
Drugs and insulin | 10 (17.2%) | 22 (37.9%) | 0.013 |
Insulin only | 34 (58.6%) | 16 (27.6%) | 0.001 |
Unknown | 4 (6.9%) | 9 (15.5%) | 0.141 |
Blood glucose (mmol/L) | 6.79 ± 2.26 | 6.84 ± 2.11 | 0.905 |
Blood pressure (mmHg) | |||
Systolic blood pressure (mmHg) | 149.28 ± 20.37 | 154.21 ± 22.27 | 0.197 |
Diastolic blood pressure (mmHg) | 89.26 ± 9.77 | 81.22 ± 10.95 | < 0.001 |
Systemic diseases | |||
Hypertension (n, %) | 30 (51.7%) | 25 (43.1%) | 0.353 |
Cardiovascular disorders (n, %) | 4 (6.9%) | 9 (15.5%) | 0.141 |
Cerebrovascular disorders (n, %) | 6 (10.3%) | 9 (15.5%) | 0.406 |
Kidney disorders (n, %) | 27 (46.6%) | 12 (20.7%) | 0.003 |
Renal dialysis (n, %) | 6 (13.6%) | 2 (4.2%) | 0.692 |
Eyes (n, %) | |||
Right | 31 (53.4%) | 27 (46.6%) | 0.458 |
Left | 27 (46.6%) | 31 (53.4%) | 0.458 |
Preoperative BCVA (LogMAR) | 1.79 ± 0.55 | 1.73 ± 0.56 | 0.536 |
Preoperative IOP (mmHg) | 15.93 ± 6.16 | 14.83 ± 3.27 | 0.230 |
Preoperative PRP (n, %) | 2 (3.5%) | 3 (5.2%) | 1.000 |
Preoperative IVI (n, %) | 5 (8.6%) | 12 (20.7%) | 0.066 |
Surgical records | |||
Vitreous tamponade (n, %) | |||
C3F8 | 5 (8.6%) | 6 (10.3%) | 0.751 |
Silicone oil | 36 (62.1%) | 23 (39.7%) | 0.016 |
BSS | 17 (29.3%) | 29 (50.0%) | 0.023 |
Cataract extraction (n, %) | 16 (27.6%) | 13 (22.4%) | 0.520 |
Retinotomy (n, %) | 24 (41.4%) | 10 (17.2%) | 0.004 |
Intraoperative findings (n, %) | |||
VH only | 0 (0.0%) | 38 (65.5%) | < 0.001 |
FVM with or without VH | 22 (37.9%) | 13 (22.4%) | 0.069 |
TRD with or without VH | 36 (62.1%) | 7 (12.1%) | < 0.001 |
Complicated with RVO | 24 (41.4%) | 20 (34.5%) | 0.444 |
Complicated with optic atrophy | 2 (3.4%) | 0 (0.0%) | 0.476 |
Early-postoperative inflammation | 6 (10.3%) | 1 (1.7%) | 0.119 |
Postoperative complications (n, %) | |||
Recurrent VH | 14 (24.1%) | 11 (19.0%) | 0.498 |
Recurrent RD | 2 (3.4%) | 0 (0.0%) | 0.476 |
NVG | 16 (27.6%) | 1 (1.7%) | < 0.001 |
Nuclear sclerosis | 31 (53.4%) | 2 (3.4%) | < 0.001 |
Secondary surgery (n, %) | 6 (10.3%) | 3 (5.2%) | 0.298 |